Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 101.01% | 125.12% | -69.94% | 1,081.28% | 1,004.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.29% | 200.24% | -34.24% | 1,225.26% | 1,289.83% |
| Operating Income | -69.29% | -200.24% | 34.24% | -1,225.26% | -1,289.83% |
| Income Before Tax | -70.00% | -198.84% | -65.01% | 0.15% | -643.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.00% | -198.84% | -65.01% | 0.15% | -643.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.00% | -198.84% | -65.01% | 0.15% | -643.38% |
| EBIT | -69.29% | -200.24% | 34.24% | -1,225.26% | -1,289.83% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 2.79% | -97.16% | -17.98% | 78.81% | -71.54% |
| Normalized Basic EPS | 2.81% | -97.20% | -46.83% | 78.81% | -71.60% |
| EPS Diluted | 2.79% | -295.84% | -17.98% | 78.81% | -71.54% |
| Normalized Diluted EPS | 2.81% | -97.20% | -46.83% | 78.81% | -71.60% |
| Average Basic Shares Outstanding | 74.88% | 51.55% | 39.84% | 371.14% | 333.34% |
| Average Diluted Shares Outstanding | 74.88% | 51.55% | 39.84% | 371.14% | 333.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |